Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
Tumor Stage
50%
Biological Subtypes
50%
Breast Cancer Subtypes
50%
Colombia
50%
Metabolic Characteristics
50%
High Complexity
50%
Molecular Signature
50%
Colombian Patients
50%
Metabolomic Analysis
50%
40 Years Old
25%
70 Years Old
25%
Clinical Variables
25%
Bogotá
25%
Elevated Levels
25%
Non-B Subtypes
12%
Untargeted Metabolomics
12%
Glycerol
12%
Clinical Follow-up
12%
Phosphatidylcholine
12%
Carbohydrates
12%
Tumor Metastasis
12%
Discriminatory Power
12%
Metabolic Alterations
12%
Energy Metabolism
12%
Ribose
12%
Early Diagnosis
12%
Glycolytic Flux
12%
Fatty Acid Composition
12%
Treatment-naïve
12%
Neoplasms
12%
LC-QTOF-MS
12%
High Heterogeneity
12%
Metabolite Coverage
12%
Glycolytic Intermediates
12%
Advanced Stage
12%
Lysophosphatidylcholine
12%
Hybrid Metabolic Phenotype
12%
Carbohydrate Metabolism
12%
Long-chain Acylcarnitines
12%
Glutamic Acid
12%
Amino Acid Profiling
12%
Plasma Metabolites
12%
Lipid Modification
12%
High Free Fatty Acid
12%
Newly Diagnosed
12%
Tumor Progression
12%
Molecular Characterization
12%
Underexploited
12%
Metabolic Reprogramming
12%
GC-QTOF-MS
12%
Colombian
12%
Luminal B
12%
Fatty Acid Catabolism
12%
Disease Progression
12%
Colombian Women
12%
Intrinsic Molecular Subtypes
12%
Metabolomics
12%
Biochemistry, Genetics and Molecular Biology
Metabolomics
50%
Metabolite
33%
Lysophosphatidylcholine
16%
Ribose
16%
Free Fatty Acids
16%
Glutamic Acid
16%
Energy Metabolism
16%
Amino Acid
16%
Blood Plasma
16%
Reprogramming
16%
Lecithin
16%
Tumor Progression
16%
Carbohydrate Metabolism
16%
Glycerol
16%
Carbohydrate
16%
Catabolism
16%
Fatty Acid
16%
Lipid
16%